Budget impact analysis of providing hospital inpatient care at home virtually, starting with two specific surgical patient groups.

health economics health services administration & management telemedicine

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
01 08 2022
Historique:
entrez: 1 8 2022
pubmed: 2 8 2022
medline: 4 8 2022
Statut: epublish

Résumé

To determine the budget impact of virtual care. We conducted a budget impact analysis of virtual care from the perspective of a large teaching hospital in the Netherlands. Virtual care included remote monitoring of vital signs and three daily remote contacts. Net budget impact over 5 years and net costs per patient per day (costs/patient/day) were calculated for different scenarios: implementation in one ward, in two different wards, in the entire hospital, and in multiple hospitals. Sensitivity analyses included best-case and worst-case scenarios, and reducing the frequency of daily remote contacts. Net budget impact over 5 years was €2 090 000 for implementation in one ward, €410 000 for two wards and €-6 206 000 for the entire hospital. Costs/patient/day in the first year were €303 for implementation in one ward, €94 for two wards and €11 for the entire hospital, decreasing in subsequent years to a mean of €259 (SD=€72), €17 (SD=€10) and €-55 (SD=€44), respectively. Projecting implementation in every Dutch hospital resulted in a net budget impact over 5 years of €-445 698 500. For this scenario, costs/patient/day decreased to €-37 in the first year, and to €54 in subsequent years in the base case. With present cost levels, virtual care only saves money if it is deployed at sufficient scale or if it can be designed such that the active involvement of health professionals is minimised. Taking a greenfield approach, involving larger numbers of hospitals, further decreases costs compared with implementing virtual care in one hospital alone.

Identifiants

pubmed: 35914920
pii: bmjopen-2021-051833
doi: 10.1136/bmjopen-2021-051833
pmc: PMC9345035
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e051833

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: GMP and CJMD have nothing to declare. WHvH has received non-restricted research grants form Novartis and Agendia BV.

Références

Chron Respir Dis. 2017 Aug;14(3):276-288
pubmed: 28774200
J Clin Oncol. 2019 Feb 20;37(6):448-452
pubmed: 30625041
J Int Med Res. 2010 Jan-Feb;38(1):242-52
pubmed: 20233536
Thorax. 2016 Apr;71(4):299-301
pubmed: 26962014
Expert Rev Med Devices. 2019 Sep;16(9):777-786
pubmed: 31379218
Value Health. 2014 Jan-Feb;17(1):5-14
pubmed: 24438712
Cochrane Database Syst Rev. 2017 Jun 26;6:CD000356
pubmed: 28651296
Health Syst Transit. 2016 Mar;18(2):1-240
pubmed: 27467715
Health Aff (Millwood). 2011 Sep;30(9):1689-97
pubmed: 21900660
Dtsch Med Wochenschr. 2007 Mar 2;132(9):417-22
pubmed: 17315117
Int J Cardiol. 2009 Jan 9;131(2):192-9
pubmed: 18222552
J Med Internet Res. 2021 Sep 1;23(9):e25195
pubmed: 34468324
Acta Orthop. 2017 Feb;88(1):41-47
pubmed: 28097941
Scand J Caring Sci. 2019 Mar;33(1):102-110
pubmed: 30112773
Ann Surg. 2020 Feb;271(2):227-229
pubmed: 31318791
J Med Internet Res. 2015 Mar 12;17(3):e63
pubmed: 25768664
CMAJ. 2011 Aug 9;183(11):E733-42
pubmed: 21746825
Eur J Heart Fail. 2008 Nov;10(11):1136-42
pubmed: 18790668
J R Soc Med. 2010 Nov;103(11):442-6
pubmed: 20959351

Auteurs

Guido M Peters (GM)

Rijnstate Research Center, Rijnstate Hospital, Arnhem, The Netherlands.
Department of Health Technology and Services Research, Faculty of Behavioural, Management & Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

Carine J M Doggen (CJM)

Rijnstate Research Center, Rijnstate Hospital, Arnhem, The Netherlands.
Department of Health Technology and Services Research, Faculty of Behavioural, Management & Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands.

Wim H van Harten (WH)

Department of Health Technology and Services Research, Faculty of Behavioural, Management & Social Sciences, Technical Medical Centre, University of Twente, Enschede, The Netherlands w.h.vanharten@utwente.nl.
Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH